s t a F F Staff Our world-renowned experts have extensive experience treating the full range of ophthalmic disorders with precision and compassion. // O p h t h a l m O l O g y U p d a t e s p e c i a l e d i t i O n 2 0 0 6
Cole Eye Institute Staff Hilel Lewis, M.D. Chairman, Division of <strong>Ophthalmology</strong> Director, Cole Eye Institute Specialty/Research Interests: Vitreoretinal surgery for complicated retinal detachment and trauma, age-related macular degeneration, diabetic retinopathy, retinal photocoagulation, instrument development Office Phone: 216.444.0430 Bela Anand-Apte, M.B.B.S., Ph.D. Ophthalmic Research Department Research Interest: Angiogenesis Office Phone: 216.445.9739 John W. Crabb, Ph.D. Ophthalmic Research Department Research Interests: Age-related macular degeneration, inherited retinal diseases Office Phone: 216.445.0425 William J. Dupps, Jr., M.D., Ph.D. * Cornea and External Disease Department Specialty/Research Interests: Cornea, cataract and refractive surgery Office Phone: 216.444.8396 Marc A. Feldman, M.D. Ophthalmic Anesthesia Specialty Interests: Ophthalmic surgery anesthesia, preoperative assessment, resident education Office Phone: 216.444.9088 Bennie H. Jeng, M.D. Cornea and External Disease Department Specialty/Research Interests: Corneal transplantation, ocular surface disease, limbal stem cell transplantation, artificial corneas, eyebanking, cataracts Office Phone: 216.445.9519 Richard E. Gans, M.D., F.A.C.S. Comprehensive <strong>Ophthalmology</strong> Department Specialty Interests: Cataract, glaucoma, diabetes Office Phone: 216.831.0120 Philip N. Goldberg, M.D. Comprehensive <strong>Ophthalmology</strong> Department Specialty Interests: Cataract, glaucoma Office Phone: 216.831.0120 Froncie A. Gutman, M.D. Vitreoretinal Department Specialty Interests: Retinal vascular diseases, laser therapy, diabetic retinopathy Office Phone: 216.444.5888 Stephanie A. Hagstrom, Ph.D. Ophthalmic Research Department Research Interests: Inherited forms of retinal degeneration, including macular degeneration and retinitis pigmentosa Office Phone: 216.445.4133 Joe G. Hollyfield, Ph.D. Ophthalmic Research Department Research Interests: Retinal degeneration, retinal diseases Office Phone: 216.445.3252 Peter K. Kaiser, M.D. Vitreoretinal Department Specialty/Research Interests: Vitreoretinal diseases, agerelated macular degeneration, retinal detachment, diabetic retinopathy, endophthalmitis, posterior segment complications of anterior segment surgery Office Phone: 216.444.6702 c O l e e y e i n s t i t U t e c l e v e l a n d c l i n i c . O r g / e y e // s t a F F
- Page 1 and 2: Cleveland Clinic Cole Eye Institute
- Page 3 and 4: i n v e s t i g a t i O n s Dear Co
- Page 5 and 6: Cole Eye Researchers Aiming to Eluc
- Page 7 and 8: useful prognostic tools and (2) the
- Page 9 and 10: Studies on Redox-Sensitive Retinal
- Page 11 and 12: Diverse Spectrum of New and Investi
- Page 13 and 14: CSNB Mouse Models Provide Valuable
- Page 15 and 16: Study Conclusively Links Haze After
- Page 17 and 18: Corneal Biomechanical Clues Studied
- Page 19 and 20: Autologous Serum Eyedrops May Offer
- Page 21 and 22: Switching from ECCE to Phacoemulsif
- Page 23 and 24: lens. that technique has also been
- Page 25 and 26: NEI-Sponsored Study Evaluating Role
- Page 27 and 28: Case Study: Five-Month-Old Boy Pres
- Page 29 and 30: Study Investigates Risk Factors for
- Page 31 and 32: however, a few months later she ret
- Page 33 and 34: each trial will enroll 189 adult pa
- Page 35 and 36: Briefly, after everting the eyelid,
- Page 37 and 38: Who We Are at the cole eye institut
- Page 39: Refractive Surgery FREEInG pATIEnTs
- Page 43 and 44: Allen S. Roth, M.D. Comprehensive O
- Page 45 and 46: International Ophthalmology Reviewe
- Page 47 and 48: Heed Ophthalmic Foundation Executiv
- Page 49 and 50: Training the Leaders of Tomorrow e
- Page 51 and 52: Continuing Medical Education e d U
- Page 53 and 54: Innovations in Ophthalmology los Ca
- Page 55 and 56: description/Objectives: This course
- Page 57 and 58: e d U c a t i O n a n d t r a i n i
- Page 59 and 60: Distinguished Lecture Series e d U
- Page 61 and 62: Research We will never stop pursuin
- Page 63 and 64: AMD Initiative for Prevention and C
- Page 65 and 66: A 3-Year, phase 3, multicenter, mas
- Page 67 and 68: Traboulsi EI. The challenges and su
- Page 69 and 70: Nakata K, Crabb JW, Hollyfield JG.
- Page 71 and 72: Journal of neuroscience Bjartmar L,
- Page 73 and 74: Singh AD. Ophthalmic oncology - pre
- Page 75: Netto MV, Ambrosio R, Jr., Wilson S
- Page 78: MKT 05-EYE-036
Change language